'Inflammatory' breast cancer
| Autor: | Sarah E Pinder, T.M. Bennett-Britton, Massimiliano Cariati, Arnie Purushotham |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Oncology
medicine.medical_specialty medicine.medical_treatment MEDLINE Breast Neoplasms Disease Inflammatory breast cancer Diagnosis Differential Breast cancer Internal medicine medicine Humans Combined Modality Therapy Neoplasm Staging Inflammation Chemotherapy business.industry Cancer Prognosis medicine.disease Radiation therapy Chemotherapy Adjuvant Radiotherapy Adjuvant Surgery business |
| Zdroj: | Surgical Oncology. 14:133-143 |
| ISSN: | 0960-7404 |
| DOI: | 10.1016/j.suronc.2005.07.004 |
| Popis: | Background “Inflammatory” breast cancer is a rare and very aggressive form of the disease characterised by rapid onset and dismal outcome. Methods This review describes the clinical and molecular aspects of inflammatory breast cancer. The relevant English language literature on of inflammatory breast cancer was searched via Medline and ISI Web of Knowledge SM Cross Search (1924–2005), cross-referencing with key articles on the subject. Results and conclusion An increasing body of evidence demonstrates that inflammatory breast cancer is a unique form of breast cancer. A prompt diagnosis and multidisciplinary approach (based on neoadjuvant chemotherapy, loco-regional treatment with surgery and/or radiotherapy, followed in some cases by adjuvant systemic therapy) are the two factors most likely to have an impact on survival. As the molecular basis of the disease is becoming increasingly more defined, new potential therapeutic targets may arise in the future. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect